Tomas Hrncir
Academy of Sciences of the Czech Republic
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Tomas Hrncir.
Proceedings of the National Academy of Sciences of the United States of America | 2009
Tanja Petnicki-Ocwieja; Tomas Hrncir; Yuen-Joyce Liu; Amlan Biswas; Tomas Hudcovic; Helena Tlaskalova-Hogenova; Koichi S. Kobayashi
Mutations in the Nod2 gene are among the strongest genetic risk factors in the pathogenesis of ileal Crohns disease, but the exact contributions of Nod2 to intestinal mucosal homeostasis are not understood. Here we show that Nod2 plays an essential role in controlling commensal bacterial flora in the intestine. Analysis of intestinal bacteria from the terminal ilea of Nod2-deficient mice showed that they harbor an increased load of commensal resident bacteria. Furthermore, Nod2-deficient mice had a diminished ability to prevent intestinal colonization of pathogenic bacteria. In vitro, intestinal crypts isolated from terminal ilea of Nod2-deficient mice were unable to kill bacteria effectively, suggesting an important role of Nod2 signaling in crypt function. Interestingly, the expression of Nod2 is dependent on the presence of commensal bacteria, because mice re-derived into germ-free conditions expressed significantly less Nod2 in their terminal ilea, and complementation of commensal bacteria into germ-free mice induced Nod2 expression. Therefore, Nod2 and intestinal commensal bacterial flora maintain a balance by regulating each other through a feedback mechanism. Dysfunction of Nod2 results in a break-down of this homeostasis.
BMC Immunology | 2008
Tomas Hrncir; Renata Stepankova; Hana Kozakova; Tomas Hudcovic; Helena Tlaskalova-Hogenova
BackgroundMammals are essentially born germ-free but the epithelial surfaces are promptly colonized by astounding numbers of bacteria soon after birth. The most extensive microbial community is harbored by the distal intestine. The gut microbiota outnumber ~10 times the total number of our somatic and germ cells. The host-microbiota relationship has evolved to become mutually beneficial. Studies in germ-free mice have shown that gut microbiota play a crucial role in the development of the immune system. The principal aim of the present study was to elucidate whether the presence of gut microbiota and the quality of a sterile diet containing various amounts of bacterial contaminants, measured by lipopolysaccharide (LPS) content, can influence maturation of the immune system in gnotobiotic mice.ResultsWe have found that the presence of gut microbiota and to a lesser extent also the LPS-rich sterile diet drive the expansion of B and T cells in Peyers patches and mesenteric lymph nodes. The most prominent was the expansion of CD4+ T cells including Foxp3-expressing T cells in mesenteric lymph nodes. Further, we have observed that both the presence of gut microbiota and the LPS-rich sterile diet influence in vitro cytokine profile of spleen cells. Both gut microbiota and LPS-rich diet increase the production of interleukin-12 and decrease the production of interleukin-4. In addition, the presence of gut microbiota increases the production of interleukin-10 and interferon-γ.ConclusionOur data clearly show that not only live gut microbiota but also microbial components (LPS) contained in sterile diet stimulate the development, expansion and function of the immune system. Finally, we would like to emphasize that the composition of diet should be regularly tested especially in all gnotobiotic models as the LPS content and other microbial components present in the diet may significantly alter the outcome of experiments.
Inflammatory Bowel Diseases | 2007
Renata Stepankova; Fiona Powrie; Olga Kofronova; Hana Kozakova; Tomas Hudcovic; Tomas Hrncir; Holm H. Uhlig; Simon Read; Zuzana Rehakova; Oldrich Benada; Pioter Heczko; Magda Strus; Paul W. Bland; Helena Tlaskalova-Hogenova
Background: The aim was to analyze the influence of intestinal microbiota on the development of intestinal inflammation. We used the model of chronic inflammation that develops spontaneously in the colon of conventional severe combined immunodeficiency (SCID) mice restored with the CD45 RBhigh subset of CD4+T cells isolated from the spleen of normal BALB/c mice. Methods: A CD4+CD45RBhigh subpopulation of T cells was purified from the spleen of conventional BALB/c mice by magnetic separation (MACS) and transferred into immunodeficient SCID mice. Germ‐free (GF) SCID mice or SCID mice monoassociated with Enterococcus faecalis, SFB (segmented filamentous bacteria), Fusobacterium mortiferum, Bacteroides distasonis, and in combination Fusobacterium mortiferum + SFB or Bacteroides distasonis + SFB were used as recipients. SCID mice were colonized by a defined cocktail of specific pathogen‐free (SPF) bacteria. Mice were evaluated 8–12 weeks after the cell transfer for clinical and morphological signs of inflammatory bowel disease (IBD). Results: After the transfer of the CD4+CD45RBhigh T‐cell subpopulation to SCID mice severe colitis was present in conventional animals and in mice colonized with a cocktail of SPF microflora plus SFB. Altered intestinal barrier in the terminal ileum of mice with severe colitis was documented by immunohistology using antibodies to ZO‐1 (zona occludens). Conclusions: Only SFB bacteria together with a defined SPF mixture were effective in triggering intestinal inflammation in the model of IBD in reconstituted SCID mice, while no colitis was detected in GF mice or in mice colonized either with SPF microflora or monoassociated only with SFB or colonized by Bacteroides distasonis + SFB or Fusobacterium mortiferum + SFB. (Inflamm Bowel Dis 2007)
Clinical and Experimental Immunology | 2011
Miloslav Kverka; Z. Zakostelska; K. Klimesova; D. Sokol; Tomas Hudcovic; Tomas Hrncir; Pavel Rossmann; J. Mrázek; Jan Kopecny; Elena F. Verdu; Helena Tlaskalova-Hogenova
Commensal bacteria have been shown to modulate the host mucosal immune system. Here, we report that oral treatment of BALB/c mice with components from the commensal, Parabacteroides distasonis, significantly reduces the severity of intestinal inflammation in murine models of acute and chronic colitis induced by dextran sulphate sodium (DSS). The membranous fraction of P. distasonis (mPd) prevented DSS‐induced increases in several proinflammatory cytokines, increased mPd‐specific serum antibodies and stabilized the intestinal microbial ecology. The anti‐colitic effect of oral mPd was not observed in severe combined immunodeficient mice and probably involved induction of specific antibody responses and stabilization of the intestinal microbiota. Our results suggest that specific bacterial components derived from the commensal bacterium, P. distasonis, may be useful in the development of new therapeutic strategies for chronic inflammatory disorders such as inflammatory bowel disease.
European Journal of Immunology | 2011
Amlan Biswas; Jeanette Wilmanski; Huamei Forsman; Tomas Hrncir; Liming Hao; Helena Tlaskalova-Hogenova; Koichi S. Kobayashi
A healthy intestinal tract is characterized by controlled homeostasis due to the balanced interaction between commensal bacteria and the host mucosal immune system. Human and animal model studies have supported the hypothesis that breakdown of this homeostasis may underlie the pathogenesis of inflammatory bowel diseases. However, it is not well understood how intestinal microflora stimulate the intestinal mucosal immune system and how such activation is regulated. Using a spontaneous, commensal bacteria‐dependent colitis model in IL‐10‐deficient mice, we investigated the role of TLR and their negative regulation in intestinal homeostasis. In addition to IL‐10−/−MyD88−/− mice, IL‐10−/−TLR4−/− mice exhibited reduced colitis compared to IL‐10−/− mice, indicating that TLR4 signaling plays an important role in inducing colitis. Interestingly, the expression of IRAK‐M, a negative regulator of TLR signaling, is dependent on intestinal commensal flora, as IRAK‐M expression was reduced in mice re‐derived into a germ‐free environment, and introduction of commensal bacteria into germ‐free mice induced IRAK‐M expression. IL‐10−/−IRAK‐M−/− mice exhibited exacerbated colitis with increased inflammatory cytokine gene expression. Therefore, this study indicates that intestinal microflora stimulate the colitogenic immune system through TLR and negative regulation of TLR signaling is essential in maintaining intestinal homeostasis.
Inflammatory Bowel Diseases | 2013
Klara Klimesova; Miloslav Kverka; Zuzana Zakostelska; Tomas Hudcovic; Tomas Hrncir; Renata Stepankova; Pavel Rossmann; Jakub Ridl; Martin Kostovcik; J. Mrázek; Jan Kopecny; Koichi S. Kobayashi; Helena Tlaskalova-Hogenova
Background:Microbial sensing by Toll-like receptors (TLR) and its negative regulation have an important role in the pathogenesis of inflammation-related cancer. In this study, we investigated the role of negative regulation of Toll-like receptors signaling and gut microbiota in the development of colitis-associated cancer in mouse model. Methods:Colitis-associated cancer was induced by azoxymethane and dextran sodium sulfate in wild-type and in interleukin-1 receptor–associated kinase M (IRAK-M)–deficient mice with or without antibiotic (ATB) treatment. Local cytokine production was analyzed by multiplex cytokine assay or enzyme-linked immunosorbent assay, and regulatory T cells were analyzed by flow cytometry. Changes in microbiota composition during tumorigenesis were analyzed by pyrosequencing, and &bgr;-glucuronidase activity was measured in intestinal content by fluorescence assay. Results:ATB treatment of wild-type mice reduced the incidence and severity of tumors. Compared with nontreated mice, ATB-treated mice had significantly lower numbers of regulatory T cells in colon, altered gut microbiota composition, and decreased &bgr;-glucuronidase activity. However, the &bgr;-glucuronidase activity was not as low as in germ-free mice. IRAK-M–deficient mice not only developed invasive tumors, but ATB-induced decrease in &bgr;-glucuronidase activity did not rescue them from severe carcinogenesis phenotype. Furthermore, IRAK-M–deficient mice had significantly increased levels of proinflammatory cytokines in the tumor tissue. Conclusions:We conclude that gut microbiota promotes tumorigenesis by increasing the exposure of gut epithelium to carcinogens and that IRAK-M–negative regulation is essential for colon cancer resistance even in conditions of altered microbiota. Therefore, gut microbiota and its metabolic activity could be potential targets for colitis-associated cancer therapy.
Allergy | 2011
Martin Schwarzer; Andreas Repa; C. Daniel; Irma Schabussova; Tomas Hrncir; B. Pot; Renata Stepankova; Tomas Hudcovic; Arnold Pollak; Helena Tlaskalova-Hogenova; Ursula Wiedermann; Hana Kozakova
To cite this article: Schwarzer M, Repa A, Daniel C, Schabussova I, Hrncir T, Pot B, Stepankova R, Hudcovic T, Pollak A, Tlaskalova‐Hogenova H, Wiedermann U, Kozakova H. Neonatal colonization of mice with Lactobacillus plantarum producing the aeroallergen Bet v 1 biases towards Th1 and T‐regulatory responses upon systemic sensitization. Allergy 2011; 66: 368–375.
Scandinavian Journal of Immunology | 2005
Helena Tlaskalova-Hogenova; Ludmila Tučková; Jiri Mestecky; Jirina Kolinska; Pavel Rossmann; Renata Stepankova; Hana Kozakova; Tomas Hudcovic; Tomas Hrncir; Lenka Frolová; Miloslav Kverka
Organisms live in continuos interaction with their environment; this interaction is of vital importance but at the same time can be life threatening. The largest and most important interface between the organism and its environment is represented by surfaces covered with epithelial cells. Of these surfaces, mucosae comprise in humans approximately 300 m2, and the skin covers approximately 1.8 m2 surface of the human body. Mucosal tissues contain two effector arms of the immune system, innate and adaptive, which operate in synergy. Interaction with commensal bacteria, which outnumber the nucleated cells of our body, occurs physiologically on epithelial surfaces; this interaction could pose the risk of inflammation. The mucosal immune system has developed a complex network of regulatory signalling cascades that is a prerequisite for proper activation but also for a timely inactivation of the pathway. As demonstrated in gnotobiotic animal models of human diseases, impaired regulation of mucosal responses to commensal bacteria plays an important role in the development of several inflammatory and autoimmune diseases.
Clinical and Experimental Immunology | 2012
Tomas Hudcovic; J. Kolinska; J. Klepetar; Renata Stepankova; T. Rezanka; Dagmar Srutkova; Martin Schwarzer; V. Erban; Z. Du; Jerry M. Wells; Tomas Hrncir; Helena Tlaskalova-Hogenova; Hana Kozakova
One of the promising approaches in the therapy of ulcerative colitis is administration of butyrate, an energy source for colonocytes, into the lumen of the colon. This study investigates the effect of butyrate producing bacterium Clostridium tyrobutyricum on dextran sodium sulphate (DSS)‐induced colitis in mice. Immunocompetent BALB/c and immunodeficient severe combined immunodeficiency (SCID) mice reared in specific‐pathogen‐free (SPF) conditions were treated intrarectally with C. tyrobutyricum 1 week prior to the induction of DSS colitis and during oral DSS treatment. Administration of DSS without C. tyrobutyricum treatment led to an appearance of clinical symptoms – bleeding, rectal prolapses and colitis‐induced increase in the antigen CD11b, a marker of infiltrating inflammatory cells in the lamina propria. The severity of colitis was similar in BALB/c and SCID mice as judged by the histological damage score and colon shortening after 7 days of DSS treatment. Both strains of mice also showed a similar reduction in tight junction (TJ) protein zonula occludens (ZO)‐1 expression and of MUC‐2 mucin depression. Highly elevated levels of cytokine tumour necrosis factor (TNF)‐α in the colon of SCID mice and of interleukin (IL)‐18 in BALB/c mice were observed. Intrarectal administration of C. tyrobutyricum prevented appearance of clinical symptoms of DSS‐colitis, restored normal MUC‐2 production, unaltered expression of TJ protein ZO‐1 and decreased levels of TNF‐α and IL‐18 in the descending colon of SCID and BALB/c mice, respectively. Some of these features can be ascribed to the increased production of butyrate in the lumen of the colon and its role in protection of barrier functions and regulation of IL‐18 expression.
Immunology Letters | 2008
Andreas Repa; Hana Kozakova; Tomas Hudcovic; Renata Stepankova; Tomas Hrncir; Helena Tlaskalova-Hogenova; Arnold Pollak; Ursula Wiedermann
The indigenous microflora plays an integrative role in the maintenance of immunological homeostasis. Several studies reported that immunological tolerance is dependent on microbial colonization of the gut. In the present study, we investigated whether the absence of the microflora influences the sensitization process to an allergen as well as the ability to develop mucosal tolerance in a mouse model of birch pollen allergy. Germ-free or conventional BALB/c mice were intranasally or intragastrically pre-treated with the major birch pollen allergen Bet v 1 prior to sensitization with this allergen. Both germ-free and conventional mice displayed comparable Th2 biased immune responses after allergic sensitization. Oral as well as intranasal tolerization led to suppression of allergen-specific serum antibodies (IgG1, IgE, IgA) as well as cytokine production by splenocytes (IL-5, IFN-gamma) in both germ-free and conventional animals. Peyers patches of germ-free animals were approximately 20 times smaller than in conventional animals, but the relative distribution of lymphocyte subpopulations was equal. We conclude that the absence of the microflora does not influence the ability to mount Th2 responses nor to establish tolerance towards the aeroallergen Bet v 1. Our findings may challenge the view that the commensal microflora is a key factor for breakdown of physiological tolerance and allergy development.